Anatara Lifesciences Ltd has released a press release.
Appendix 4C & Q1 FY22 Activities Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Anatara Lifesciences Limited (ASX: ANR) Annual Report to Shareholders
- Investor Presentation
- Appendix 4E & Financial Report 30 June 2021
- Anatara Lifesciences Limited (ASX: ANR) Launches IBS-D Clinical Trial Recruitment Website
- Successful Piglet Study
Later from Anatara Lifesciences
- AGM CEO Presentation
- Chairmans Address to Shareholders
- Application for quotation of securities - ANR
- Notification regarding unquoted securities - ANR
- Change of Director's Interest Notice
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences